البلد: كندا
اللغة: الإنجليزية
المصدر: Health Canada
MINOXIDIL
JOHNSON & JOHNSON INC
D11AX01
MINOXIDIL, TOPICAL
5%
AEROSOL, FOAM
MINOXIDIL 5%
TOPICAL
60G
OTC
MISC. SKIN AND MUCOUS MEMBRANE AGENTS
Active ingredient group (AIG) number: 0114429004; AHFS:
APPROVED
2017-05-01
_Product Monograph Master Template _ _ _ _Men’s ROGAINE® Minoxidil Topical Solution _ _Men’s ROGAINE® Foam 5% Minoxidil Foam _ _Women’s ROGAINE® Foam 5% Minoxidil Foam _ _ _ _Page 1 of 66_ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION MEN’S ROGAINE® Minoxidil Topical Solution 20 mg/mL (2% w/v) Men’s ROGAINE® FOAM 5% Minoxidil Foam 50 mg/g (5% w/w) Women’s ROGAINE® FOAM 5% Minoxidil Foam 50 mg/g (5%w/w) Hair Regrowth Treatment Johnson & Johnson Inc. 88 McNabb Street Markham, ON L3R 5L2 Date of Initial Authorization: OCT 17, 2003 Date of Revision: JAN 20, 2022 Submission Control Number: 251296 _Product Monograph Master Template _ _ _ _Men’s ROGAINE® Minoxidil Topical Solution _ _Men’s ROGAINE® Foam 5% Minoxidil Foam _ _Women’s ROGAINE® Foam 5% Minoxidil Foam _ _ _ _Page 2 of 66_ TABLE OF CONTENTS TABLE OF CONTENTS ................................................................................................................2 PART I: HEALTH PROFESSIONAL INFORMATION .......................................................................4 1 INDICATIONS ................................................................................................................4 1.1 Pediatrics ............................................................................................................4 1.2 Geriatrics.............................................................................................................4 2 CONTRAINDICATIONS ...................................................................................................4 4 DOSAGE AND ADMINISTRATION...................................................................................5 4.1 Dosing Considerations .........................................................................................5 4.2 Recommended Dose and Dosage Adjustment.......................................................5 4.4 Administration.....................................................................................................6 4.5 Misse اقرأ الوثيقة كاملة